TY - JOUR
T1 - Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
AU - Ban, Hiroshi
AU - Nishishita, Naoki
AU - Fusaki, Noemi
AU - Tabata, Toshiaki
AU - Saeki, Koichi
AU - Shikamura, Masayuki
AU - Takada, Nozomi
AU - Inoue, Makoto
AU - Hasegawa, Mamoru
AU - Kawamata, Shin
AU - Nishikawa, Shin Ichi
PY - 2011/8/23
Y1 - 2011/8/23
N2 - After the first report of induced pluripotent stem cells (iPSCs), considerable efforts have been made to develop more efficient methods for generating iPSCs without foreign gene insertions. Here we show that Sendai virus vector, an RNA virus vector that carries no risk of integrating into the host genome, is a practical solution for the efficient generation of safer iPSCs. We improved the Sendai virus vectors by introducing temperature-sensitive mutations so that the vectors could be easily removed at non-permissive temperatures. Using these vectors enabled the efficient production of viral/factor-free iPSCs from both human fibroblasts and CD34 + cord blood cells. Temperature-shift treatment was more effective in eliminating remaining viral vector-related genes. The resulting iPSCs expressed human embryonic stem cell markers and exhibited pluripotency. We suggest that generation of transgene-free iPSCs from cord blood cells should be an important step in providing allogeneic iPSC-derived therapy in the future.
AB - After the first report of induced pluripotent stem cells (iPSCs), considerable efforts have been made to develop more efficient methods for generating iPSCs without foreign gene insertions. Here we show that Sendai virus vector, an RNA virus vector that carries no risk of integrating into the host genome, is a practical solution for the efficient generation of safer iPSCs. We improved the Sendai virus vectors by introducing temperature-sensitive mutations so that the vectors could be easily removed at non-permissive temperatures. Using these vectors enabled the efficient production of viral/factor-free iPSCs from both human fibroblasts and CD34 + cord blood cells. Temperature-shift treatment was more effective in eliminating remaining viral vector-related genes. The resulting iPSCs expressed human embryonic stem cell markers and exhibited pluripotency. We suggest that generation of transgene-free iPSCs from cord blood cells should be an important step in providing allogeneic iPSC-derived therapy in the future.
UR - http://www.scopus.com/inward/record.url?scp=80052157957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052157957&partnerID=8YFLogxK
U2 - 10.1073/pnas.1103509108
DO - 10.1073/pnas.1103509108
M3 - Article
C2 - 21821793
AN - SCOPUS:80052157957
SN - 0027-8424
VL - 108
SP - 14234
EP - 14239
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 34
ER -